About 2,373 results

ALLMedicine™ Anal Cancer Center

Research & Reviews  783 results

Advancing anal cancer prevention in men.
The Lancet. HIV; Burchell AN, Grennan T

Aug 3rd, 2021 - Advancing anal cancer prevention in men.|2021|Burchell AN,Grennan T,|

Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithe...
The Lancet. HIV; Wei F, Gaisa MM et. al.

Aug 3rd, 2021 - Robust age-specific estimates of anal human papillomavirus (HPV) and high-grade squamous intraepithelial lesions (HSIL) in men can inform anal cancer prevention efforts. We aimed to evaluate the age-specific prevalence of anal HPV, HSIL, and their...

Characterisation of anal intraepithelial neoplasia and anal cancer in HIV-positive men ...
International Journal of Cancer; van der Zee RP, Meijer CJLM et. al.

Jul 27th, 2021 - Human papillomavirus (HPV)-induced anal intraepithelial neoplasia (AIN, graded 1-3) is highly prevalent in HIV-positive (HIV+) men-who-have-sex-with-men (MSM), but only a minority of lesions progresses to cancer. This study aimed to characterise c...

Quality of Life and Sexual Function of Men Who Have Sex With Men Treated for Anal Cance...
The Journal of Sexual Medicine; Mauro GP, da Conceição Vasconcelos KGM et. al.

Jul 14th, 2021 - Anal cancer is a rare disease, more prevalent in women. Men who have sex with men (MSM) are a high-risk neglected population. The primary objective was to assess quality of life (QoL) and sexual function (SxF) among MSM treated with radical chemor...

The association between protease inhibitors and anal cancer outcomes in veterans living...
BMC Cancer; Yoder AK, Lakomy DS et. al.

Jul 7th, 2021 - The incidence of anal squamous cell carcinoma has been increasing, particularly in people living with HIV (PLWH). There is concern that radiosensitizing drugs, such as protease inhibitors, commonly used in the management of HIV, may increase toxic...

see more →

Guidelines  7 results

Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.
Annals of Oncology : Official Journal of the European Soc... Rao S, Guren MG et. al.

Jun 28th, 2021 - Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.|2021|Rao S,Guren MG,Khan K,Brown G,Renehan AG,|

Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in ...
Journal of the National Comprehensive Cancer Network : JN... Reid E, Suneja G et. al.

Aug 14th, 2018 - People living with HIV (PLWH) are diagnosed with cancer at an increased rate over the general population and generally have a higher mortality due to delayed diagnoses, advanced cancer stage, comorbidities, immunosuppression, and cancer treatment ...

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JN... Benson AB, Venook AP et. al.

Jul 15th, 2018 - The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain les...

2016 IANS International Guidelines for Practice Standards in the Detection of Anal Canc...
Journal of Lower Genital Tract Disease; Hillman RJ, Cuming T et. al.

Aug 26th, 2016 - To define minimum standards for provision of services and clinical practice in the investigation of anal cancer precursors. After initial face to face meetings of experts at the International Papillomavirus meeting in Lisbon, September 17 to 21, 2...

Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and ...
Annals of Oncology : Official Journal of the European Soc... Glynne-Jones R, Nilsson PJ et. al.

Jul 9th, 2014 - Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2014|Glynne-Jones R,Nilsson PJ,Aschele C,Goh V,Peiffert D,|diagnosis,therapy,standards,

see more →

Drugs  2 results see all →

Clinicaltrials.gov  45 results

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

May 5th, 2020 - PRIMARY OBJECTIVE: I. To evaluate whether therapy with nivolumab following combined modality therapy (CMT) improves disease-free survival (DFS) compared with observation in patients with high risk anal carcinoma. SECONDARY OBJECTIVES: I. To compar...

Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer

Apr 27th, 2020 - In this Phase 1/2 study, the investigators will conduct a safety and efficacy study of the combination of BMX-001 with standard radiation therapy (RT) and concurrent 5-fluorouracil (5FU)/mitomycin in newly diagnosed Anal Squamous Cell Carcinoma (A...

QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT

Apr 9th, 2020 - The objectives of this study are three-fold. First, we would like to learn and compare the doses of radiation received by the tumor and the normal tissues in anal cancer patients treated with IMRT, and in those treated with conventional radiothera...

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

Apr 1st, 2020 - PRIMARY OBJECTIVES: I. To define the proportion of participants who develop treatment failure at 2 years, defined as the occurrence of distant or any nodal metastases or recurrence of cancer requiring chemotherapy (CMT), defined as a cancer that n...

Seville Cohort of People Living With HIV at Risk for Anal Cancer

Jan 18th, 2020 - The development of anal precancerous squamous intraepithelial lesions (SIL) and cancer of the anus is mainly caused by infection with high-risk human papillomavirus genotypes (HR-HPV). There is increasing awareness of marked (40 to 130-fold) risk ...

see more →

News  105 results

Call to Eradicate All Types of HPV Cancers, not Just Cervical

Mar 25th, 2021 - The World Health Organization's (WHO) call for the elimination of cervical cancer worldwide is a laudable goal, and one that many organizations across the globe have endorsed. Yet some would say that that goal goes only halfway, and that the real ...

The Vanguard of HIV Care: Don't Forget This Screening

Feb 22nd, 2021 - HIV-positive patients who are adherent with antiretroviral medications are achieving undetectable or very low levels of HIV viremia and living longer. In response, clinical care is continually adapting to the dramatically altered natural history o...

Adults With HIV at Increased Risk for Anal Carcinoma After Anogenital Warts

Jan 25th, 2021 - (Reuters Health) - Adults living with HIV who have a history of anogenital warts may be at increased risk for developing anal carcinoma, a recent study suggests. Researchers examined data on 6,515 adults living with HIV who received care at one of...

'Reshaping' Radiotherapy May Reduce Female Sexual Dysfunction

Nov 5th, 2020 - Radiotherapy plays an important role in the treatment of anal cancer, but many female survivors treated with pelvic radiotherapy develop long-term sexual problems. A new study shows that it is possible to reduce the dose of radiation reaching the ...

Combo Carboplatin/Paclitaxel New Standard of Care for Anal Cancer

Jun 25th, 2020 - UPDATED with comments  June 25, 2020 // This story has been updated with comments about the study from Dr Michael Buckstein. Carboplatin plus paclitaxel should now be considered the standard of care for patients with advanced anal cancer, in place...

see more →

Patient Education  7 results see all →